Methods: This observational study was conducted at an ED with an annual census of 80,000 visits, with approximately 400 for AIS. The cohort consisted of adult patients who presented to the ED within 24 hours of stroke symptom onset. Blood pressure measured at triage by a nurse blinded to the study. Stroke severity was measured using the National Institutes of Health Scale (NIHSS).
Study Objectives: To determine whether routine laboratory parameters are associated with stroke severity as measured by the National Institutes of Health Scale (NHISS).
Methods: This was a prospective observational study of consecutive patients with an ultimate diagnosis of ischemic stroke presenting to the emergency department (ED) at a primary stroke center. Serum laboratory values were obtained for patients per our stroke protocol, and included a complete blood count, electrolytes, HbA1c, and troponin. These laboratory results were considered as potential predictors of stroke severity as measured by the NIHSS by personnel certified in NIHSS administration. All calculated p-values were 2-sided and p-values less than 0.05 were considered statistically significant. Statistical analyses were performed using the JMP 12.0 software package (SAS Institute, INC; Cary, North Carolina).
Results: Of the 670 patients, 46% were female, with a median age of 71 and an interquartile range (IQR) of 60-80 years. Univariate models looking at each laboratory variable versus ED NIHSS only revealed the white blood cell count (WBC) to be significantly correlated with stroke severity with a higher WBC being associated with a higher stroke severity or worse stroke (P<0.0001). This association retained statistical significance in a multivariate model that included all the other labs, age and sex (P<0.0001). The median WBC was 8.2 cells/yL with an IQR of 6.5 to 10.7, and a range of 3-31. There was no statistically significant difference of WBC across sex or age.
Conclusions: Early leukocytosis in AIS appears to be associated with higher stroke severity.
Evaluation of Fosphenytoin Loading Doses in Obese Patients
Wex N, Van Matre E, Jacknin G, Paavola N/University of Colorado Hospital, Aurora, CO; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO Study Objectives: The 2016 Epilepsy Guidelines recommend a fosphenytoin loading dose of 20 mg/kg with a maximum of 1500 mg. However, this is not supported by quality evidence, and there is limited data for how to address loading obese patients. This study sought to evaluate the percent target plasma concentration attainment and safety for the treatment of status epilepticus in obese patients receiving an uncapped fosphenytoin loading dose (20 mg/kg).
Methods: Retrospective cohort of obese patients (>120% ideal body weight) with status epilepticus requiring a fosphenytoin loading dose at an academic medical center between July 1, 2013 and July 1, 2017. Inclusion criteria were fosphenytoin loading dose of 20 mg/kg and free and total level obtained within 24 hours post-load. The primary end-point was the percent of total phenytoin plasma concentrations within therapeutic range post-load (15 -30 mcg/ml). Secondary endpoints included percent free phenytoin plasma concentrations within therapeutic range post-load (1.5 -3 mcg/ ml), time to level obtainment, seizure cessation, and adverse effects reported secondary to infusion.
Results: Fifty-eight obese patients met inclusion criteria for the study. The mean baseline characteristics were 53% male, age 57.7 years, weight 93.4 kg, percent over ideal body weight 51%, body mass index 32.8 kg/m 2 , total loading dose 1738 mg, and albumin 3.3 g/dL. The primary outcome for percent of total target plasma concentration attainment was 60.3% (35/58). The secondary outcomes were as follows: percent of free target plasma concentration attainment was 75.8% (44/58), mean post-load level was 8.4 hours, and 12 patients had seizures present on next EEG. No adverse effects were noted for any patients.
Conclusions: The data indicates the utilization of an uncapped fosphenytoin loading dose is a safe and effective method for the treatment of status epilepticus in obese patients. This is in contrast to the recent guideline recommendation of capping fosphenytoin dosing at 1500 mg and may increase the probability of plasma concentration target attainment in obese patients in status epilepticus. Study Objectives: Assessment of the accurate prognosis with spontaneous circulation after cardiac arrest is crucial in deciding to withdrawal of life sustaining treatment for patients predicted poor neurologic outcome. We investigated the accuracy of systemic multimodal approach to predict the poor neurologic outcome of patients applied targeted temperature management (TTM).
Methods: We performed retrospective analysis of prospective cohort data from a single teaching hospital operating critical pathway for TTM between September 2011 and December 2016. We used the hierarchical CART model to find the optimal model to predict the poor neurologic outcome of 192 enrolled patients. The primary outcome was poor neurologic outcome (cerebral performance category (CPC) scale, categories 3 to 5 [CPC 3 to 5]) at 1 month.
Results: Out of 291 consecutive patients, 192 met the study inclusion criteria. Among them, 103 patients (53.6%) had poor neurologic outcome at 1 month. Most predictive model which is combining brain computerized tomography, serum neuron specific enolase, evoked potential, pupil light reflex and electroencephalogram had 6 nodes and an area under the receiver operating characteristic curve was 0.911(0.872-0.950).
Conclusions: On the basis of our stepwise model using 5 modalities for predicting neurologic outcome, patients can be readily predicted survival with poor outcome at 1 month. This systemic multimodal prediction model may provide clinicians with a practical tool for patients with TTM after return of spontaneous circulation. Study Objectives: Sudden cardiac arrest in athletes is a rare event, yet remains a leading causes of death in athletes. A small percent of these events is due to commotio cordis (CC), secondary to direct striking trauma to the chest. Many athletes wear various types of athletic chest protectors (ACP) to help prevent the incidence of CC. Studies indicate that almost 40% of cases occurred despite the use of ACPs. There has been little research to evaluate the impact of these ACPs on the quality of cardiopulmonary resuscitation (CPR) compressions. Numerous studies have indicated that the quality of CPR during a cardiac arrest is correlated to patient outcome and overall mortality. In this study, we aim to observe: (1) whether the presence of ACPs
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